# Tim Somervaille

Source: https://onco.cc/people/tim-somervaille/  
OnCo record `tim-somervaille` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Haematologist and Senior Group Leader at CRUK Manchester Institute studying the transcriptional drivers of acute myeloid leukaemia.

## Summary

Tim Somervaille is a Senior Group Leader at the Cancer Research UK Manchester Institute, where his Leukaemia Biology laboratory investigates transcription factors and epigenetic regulators that sustain acute myeloid leukaemia. He is also a consultant haematologist at The Christie NHS Foundation Trust. His group has identified FOXC1 derepression as a recurrent feature in AML and explored EP300/CBP bromodomain inhibition as a therapeutic strategy.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: clinician-scientist; leukaemia; haematology
- Role: Senior Group Leader
- Specialisms: Acute myeloid leukaemia; Leukaemia biology; Haematology

## Sources

- Institution profile: https://www.cruk.manchester.ac.uk/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Somervaille+TC%5BAuthor%5D

## Connected records

- cancers: [Acute myeloid leukaemia](https://onco.cc/cancers/aml/)
- institutions: [Cancer Research UK Manchester Institute](https://onco.cc/institutions/cruk-manchester-institute/)

---
JSON: https://onco.cc/api/v1/entities/tim-somervaille.json